Call for Abstract

International Conference and Expo on Medical Virology, will be organized around the theme “Current concepts and research trends in the field of medical virology”

Medical Virology 2017 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Medical Virology 2017

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Most of the acute illness infectious diseases associated with a high mortality rate characterized by multisystem involvement which are often caused by  viruses (or bacterial disease/ Pathogenic microorganisms) such as Ebola, Hepatitis and Marburg. In such cases prevention, diagnosis and treatment of viral diseases require Clinical Biotherapeutics, research investigations and novel technologies. Epidemics usually begins with a single case acquired from an unknown reservoir in nature  such as bats are suspected and spread mainly through close contact with sick persons or their body fluids, either at home or in the hospital.

Viral Molecular medicine is an immense field, which enables to develop molecular interventions to precise molecular and genetic flaw of infectious and or disease as result of physical, chemical, biological and medical techniques are being used to characterise molecular structures and mechanisms. This Viral molecular medicine field of study enables not only emphasizes cellular and molecular phenomena also gives a scope to interventions instead of previous conceptual and observations.

  • Track 2-1Viral gene therapy
  • Track 2-2Viral vectors
  • Track 2-3Protozoal Viriotherapy
  • Track 2-4Viral Immune Therapy
  • Track 2-5Oncolitic Viriotherapy
  • Track 2-6Antiviral drugs and adjuvants
  • Track 2-7DNA Immunization
  • Track 2-8Antigen presenting cell-targeted therapy

We know that viruses are obligatory and intracellular parasites, since that replication requires the pathways and functions of the host cell. As a consequence, it is laborious to characterize specific functions of infectious viruses as god enough targets for anti-infective therapy. Nevertheless, in the past 50 years significant progress has been made towards the development of effective and specific antivirals. Particularly, HIV, Hepatitis type B & C viruses, which are of causing chronic infections and those are affecting millions of mankind world-wide, are a extensive spotlight of research in antivirals. Earlier these antivirals were directed against virus-specific enzymes but nowadays research. Initially, antivirals were mainly directed against virus-specific enzymes; currently, drugs are inhibiting the steps of infectious viral entry or release has been developed. Enlightened paths towards drug development have become progressive successful as a result of characterization structure and function of viral proteins and molecular mechanisms of virus-host interactions. Innovative strategies are exploring in essential research or preclinical studies including paths to target host factors those are important for replication of infectious virus, exploitation of the innate immune response system along with utilisation of gene silencing strategies targeting at meddlesome with the gene expression of infectious virus. Nowadays various virostatics targeting various viral replication steps are approved to treat critical infectious viral diseases. Even though, the employment of such drugs is finite by the swift development of antiviral resistance, which results a substantial complications of contemporary antiviral therapy.

  • Track 3-1Antiviral drug
  • Track 3-2VTAs (Virus-targeting antivirals)
  • Track 3-3HTAs (Host-targeting antivirals)
  • Track 3-4Antiviral mechanisms of human defensins
  • Track 3-5Antiviral drug resistance

To Identify, characterise, quantify, and predict the changes in host response that distinguish between pathogenic and attenuated viruses that lack key virulence factors of infectious, which results to identify unique, novel, and regular molecular signatures in the host response to wide variety of infectious viruses which represents therapeutic intervention of future targets for those which are causing such as  gastroenteritis leading to morbidity and mortality, diarrhoea-related deaths, necrotising enterocolitis (NEC) in neonates and seizures causing viruses by utilising multiple model systems such as in vitro cell culture syustems, primary cell culture, non-human primates as  whole animal models. Most of the viruses such as caliciviruses, norovirus and etc., are using as model systems to study about basic mechanisms of pathogenesis, molecular mechanisms of genome translation and replication.

  • Track 4-1Calu-3 cells (Cultured Human Airway Epithelial Cells)
  • Track 4-2Mouse Embryonic Stem Cells
  • Track 4-3hES cells (Pluripotent Human Embryonic Stem cells)
  • Track 4-4HTBEs (Human Tracheobronchial Epithelial cells)
  • Track 4-5MEFs (Mouse Embryonic Fibroblast system)
  • Track 4-6Simian Virology
  • Track 4-7Antisense technology
  • Track 4-8Anti-viral therapies
  • Track 4-9Small molecule inhibitors
  • Track 4-10Nucleotide analogues

Around the world medical researchers and doctors are trying to cure cancer since some centuries and also been succeeded in some cases and helped millions of people to reprieve with treatment methods including surgery, radiation, chemotherapy, hormone therapy, and biological therapy, even though nowadays treatment methods are of having so many side effects especially in cancer patients are fatigued, weak, nauseous hair loss and irritated skin, and the drug efficiency is also very poor, so patients are badly needed toxic treatment in lot to receive benefits from these treatments. Viral nanoparticles are being revolutionized cancer treatment, not only as a safer, also more specific form of cancer treatment, which is emerging imaging tool.   

  • Track 5-1Production and engineering of VNPs
  • Track 5-2Production of VNPs and VLPs
  • Track 5-3Genetic engineering
  • Track 5-4Chemical engineering and cargo encapsulation
  • Track 5-5Vaccines based on VLPs and chimeric VNPs
  • Track 5-6From engineering to potential applications in medicine
  • Track 5-7Receptor-targeted delivery
  • Track 5-8Receptor-targeted imaging
  • Track 5-9Viruses as nanocarriers
  • Track 5-10Viruses for the treatment of cancer
  • Track 5-11Bacterial infections
  • Track 5-12Toxicity and biodistribution
  • Track 5-13Immune stimulation

Waterborne enteric Viruses belongs to such as reovirus, rotavirus, poliovirus, coxsackievirus, echovirus, enterovirus, hepatitis A virus,  Norwalk virus, astrovirus, calicivirus, Snow Mountain agent, small round structured virus,  adenovirus strains 3, 7, 40, and 41 are threatening not only animal health also to mankind’s health. Extensive research has documented the risk of infectious viruses, are of host specific those are of cause wide range of diseases such as ocular and respiratory infections to gastroenteritis, hepatitis, myocarditis, and aseptic meningitis; in almost living beings from contact with contaminated water, current methods that which is bacterial indicator base of evaluation quality of water, are often ineffectual proxies for infectious viruses. RNA viruses are of causing gastroenteritis with diarrhea and/or vomiting, fever. Rotavirus is causative agent for gastroenteritis. With progressive molecular analysis, infectious viruses from key host groups should be targeted directly by using either PCR amplification or hybridization with a high level of sensitivity and specificity. Analysis which provides information about multispecies to control and determine, based on loading and exposure of infectious virus to evaluate potential risks to animal health and could indicate the potential for the presence of other zoonotic infectious organisms. Need to be better understanding of prevalence and environmental distribution of nonhuman enteric viruses, emerging of advanced sensitive methods for specific analysis will facilitates the utilisation of microbes for library independent source tracking and assessment tools for water quality.

  • Track 6-1Gene chips
  • Track 6-2Docking proteins, antibodies, and genetic sequences
  • Track 6-3Nitrocellulose enzyme immune-sorbent assay (NC-EIA)
  • Track 6-4Hybridization or antibody-based assays
  • Track 6-5ELISA
  • Track 6-6Most-Probable-Number (MPN)–PCR
  • Track 6-7RT-PCR
  • Track 6-8Plaque forming units (PFU)

DNA immunization is a novel method used to efficiently fortify humoral and cellular immune responses to protein antigens. Viral vaccines contain either inactivated viruses or constricted viruses .Inactive viral vaccines contain a virus, which have lost their ability to replicate and in order for it to bring about a response it contains more antigen than live immunizations. Allergy immunotherapy is a clinically documented efficacious treatment, which may considerably reduce the patient’s allergic symptoms and the need for traditional, symptom-relieving medication. Antiviral drugs are a class of medication utilized particularly for treating viral contaminations.

  • Track 7-1DNA vaccines
  • Track 7-2Reprogramming of viruses
  • Track 7-3Antigen presenting cell-targeted therapy
  • Track 7-4Safety evaluation of viral vaccines
  • Track 7-5Antiviral drugs and adjuvants
  • Track 7-6Viral vaccines
  • Track 7-7Gene therapy for viral infections
  • Track 7-8Antibody therapy against viruses
  • Track 7-9Interleukin immune therapy
  • Track 7-10Viral Aptamers as therapeutics

VLPs (Virus-like particles) are proteins structures that which are of mimic the confirmation and organisation of native viruses without viral genome with potential yielding, safer and economical vaccine candidates. GlaxoSmithKline's Engerix (Hepatitis B Virus) and Cervarix (Human Papilloma Virus), and Merck and Co., Inc.'s Recombivax HB (Hepatitis B Virus) and Gardasil (Human Papilloma Virus) are some of the examples which are of using VLP-based vaccines currently commercialized worldwide. Influenza virus, parvovirus, Norwalk and various chimeric VLPs are in clinical trials or undergoing preclinical evaluation and other VLP-based vaccine candidates are restricted to small-scale fundamental research. Even though successful VLP-based vaccine blockbusters are in market but still need of new-generation VLP-based technology for either therapeutic or prophylactic vaccination against prevalent and emergent diseases.

  • Track 8-1Diagnostics
  • Track 8-2Nanotechnology
  • Track 8-3Vaccination
  • Track 8-4Gene therapy
  • Track 8-5VLPs in plants for edible vaccine production
  • Track 8-6Design of vaccine subunit
  • Track 8-7Defective viruses
  • Track 8-8Pseudoviruses
  • Track 8-9Viriods
  • Track 8-10Prions

Viral Biotechnology interdisciplinary of Biotechnology is a scientific and research field having extensive scope, which is using research tools from biochemistry and molecular biology to characterise and solve problems such as infectious diseases being caused by viruses. Biotechnologists are being used to study the genetic material of viruses including other distinct microbial machinery to understand factors that are contributing to human diseases.  Emerging technologies can be used to develop diagnostic tests that enable sensitive and quick analysis and characterisation of the viral infectious diseases leads to develop dynamic treatments and methodologies

  • Track 9-1Engineered Cattles to produce human antibodies against viruses
  • Track 9-2De-chaperoning antivirals
  • Track 9-3Biomedical applications
  • Track 9-4Genomics study
  • Track 9-5DNA Sequencing
  • Track 9-6Using Biotechnology to Detect Inherited viral diseases
  • Track 9-7Using Biotechnology to detect infectious viral diseases
  • Track 9-8Recombinant viral vectors fort gene therapy
  • Track 9-9Development of helper-free packaging cell lines

As per the World Health Organization (WHO) records, nearly 20% of the cancers in the world as a result of chronic infections, in developing countries roughly 15% of human cancers  are characterised and with higher incidence of viruses only. Since past century relation between viruses and cancer is one of the crucial discoveries in cancer research. As a result of key observations in the infectious nature of particular cancers are having extensive significance in prevention, diagnosis, and therapeutics. Nowadays research in viral oncology area continues to be brisk, including novel significance and primitive studies of viral oncogenesis and translational research from basic virology to treat cancers of infectious cancers. 

 

  • Track 10-1Parainfluenza Viruses
  • Track 10-2Viral oncogenetic mechanisms
  • Track 10-3Direct immunogens
  • Track 10-4Human Oncogenic DNA viruses
  • Track 10-5Animal oncogenic DNA viruses
  • Track 10-6Human oncogenic RNA viruses
  • Track 10-7Animal oncogenic RNA viruses

Viral Immunology is delivering the cutting-edge focus on translational research on unusual, emerging, and under-studied infectious viruses, with exceptional focus on analysing mutual relationships among external viruses and internal immunity, including the role of innate and adaptive immunity in the establishment, containment and/or breakthrough of infectious diseases of viruses, which is resulting as a cancer, includes vaccine and adjuvants strategies.

  • Track 11-1Restriction factors
  • Track 11-2Antibodies
  • Track 11-3Interferons
  • Track 11-4Cytokines
  • Track 11-5Apoptosis & Innate immunity
  • Track 11-6Viral immune evasion

Pediatric virology is not an isolated discipline. Rather, the syndromes associated with viral infection are modified by the unique characteristics of infancy and childhood. Fortunately for the paediatrician, and certainly for children, viral infections in childhood are rarely fatal, and are almost never serious. Future efforts of the paediatrician and virologist should be directed toward increased foetal salvage as with rubella and the prevention of severe, viral lower respiratory tract disease.

  • Track 12-1Respiratory Disease of Viral Etiology
  • Track 12-2Viral Respiratory Disease in Children
  • Track 12-3Viral Infections of the Fetus and Newborn

Transmission of viruses is the process by where viruses will spread between the hosts, including either members of the similar hosts or spread to different species in case of viruses can cross beyond the species barriers, which results in emerging new diseases are threat to health of people.

  • Track 13-1Transmission of Epidemic viruses in humans and other animals
  • Track 13-2Environmental and demographic Barriers for viral transmission
  • Track 13-3Ecological barriers for viral transmission
  • Track 13-4Host barriers for viral transmission
  • Track 13-5Extant host range as a factor for viral Transmission
  • Track 13-6Adaptation of post transmission of viruses
  • Track 13-7Evolution of viruses

Human Virology deals with diseases due to the infectious viruses in humans, viruses those which are infecting humans can target essentially in every tissue of the body which results further deadly diseases. Characterising and understanding infectious disease processes must be refined for all viruses separately. An account of the analysis of infectious virus role in human disease, thus have to be significant advances to understand such agents and breakthrough in prevention and treatment of infectious diseases. Nevertheless, infectious diseases caused by viruses endure to be a macro constituent of the morbidity and premature mortality burden for mankind. Due to the emergence of viruses is constant threat, such as HIV, Hepatitis, Ebola, Zika virus, Avian influenza, Flu (influenza), HPV, Herpes & SARS and etc. which are of our most common experience of infectious viruses caus of viral pneumonia, Herpes, Human papillomavirus (HPV), AIDs, Infectious mononucleosis, mumps, measles, rubella, Shingles, Viral gastroenteritis (stomach flu), Viral meningitis, Hepatitis and etc.,

  • Track 14-1Sexually Transmitted Diseases
  • Track 14-2Central Nervous System Infections
  • Track 14-3Gastrointestinal Tract Infections
  • Track 14-4Respiratory Tract Infections
  • Track 14-5Eye Infections
  • Track 14-6Urinary Tract Infections
  • Track 14-7Skin and Soft Tissue Infections
  • Track 14-8Congenital Infections
  • Track 14-9Perinatal Infections

Clinical Virology is interdisciplinary of virology/medical virology and healthcare science which characterise resolve the safety and efficacy of medications, devices, diagnostic products and treatment regimens intended for mankind, which can be utilise for prevention, treatment & diagnose for alleviate the infectious viral diseases. When comparing with clinical practice, clinical research is distinct that which gives evidences collected results to found therapeutic approaches for infectious viral diseases. The human immunodeficiency virus is a lentivirus(subgroup of retroviruses) that causes HIV infection and acquired immunodeficiency syndrome. HIV diagnosis is done by testing your blood or saliva for antibodies to the virus. HIV/AIDS clinical trials are research studies done to look at new ways to prevent, detect, or treat HIV/AIDS. Clinical Trials are the fastest way to determine if new medical approaches to HIV/AIDS are safe and effective in people.

  • Track 15-1HIV Associated Diseases
  • Track 15-2Swine flu outbreak,Prevention & Treatment
  • Track 15-3Corona Viruses
  • Track 15-4Severe acute respiratory syndrome
  • Track 15-5Polio virus
  • Track 15-6Oncovirus
  • Track 15-7Virus Receptors & Viral Entry
  • Track 15-8Herpes & Pox Viruses
  • Track 15-9Filoviruses-Ebola virus & Westnile Viruses
  • Track 15-10Viral meningitis
  • Track 15-11Influenza Viruses
  • Track 15-12HIV and retroviral transmission and prevention
  • Track 15-13HPV & Other Sexually Transmitted Diseases

Viruses are contributing significant global burden of infectious diseases. Many of the infections are causing mild effects of diseases, but, when the individuals are mal-nourished, negotiable immunity at the late age and the very young age, viruses may cause severe infectious diseases in such susceptible. The development of potential assays for the diagnosis of these diseases as result of current observations in the viral aetiology of many infectious diseases, and considerable progress in our insight of the history and the steps of the viral life cycle, pathogenesis and chemotherapy of infectious diseases.

  • Track 16-1Viral Morphology
  • Track 16-2Viral Biochemistry
  • Track 16-3Cultivation of Viruses
  • Track 16-4Role of viruses in evolution
  • Track 16-5Viral Diversity

Diagnosis of viral infections is essential and now it can be considered fundamental for medical practices. There are distinctive methods, including viral culture, antigen detection, nucleic acid detection, and serology. Which results in, breath-taking breakthrough in antiviral therapeutics has been increasing the need for specific viral diagnoses. Nucleic acid chemistry is providing emerging tools as a result of technological development. Day by day most of the patients are of at risk due to the opportunistic infections of epidemic viruses such as HIV/AIDS, Coronaviruses (MERS-CoV, SARS), Zika Virus, Influenza (seasonal, pandemic), Ebola Virus, HPV, Smallpox and human monkeypox.

  • Track 17-1Isolation of viruses
  • Track 17-2Indirect Examination of viruses
  • Track 17-3Direct demonstration of viruses
  • Track 17-4Fundamental Serology Techniques
  • Track 17-5Emerging Serology Techniques

Context of the propagative research of infectious virus: prompting the utilization of progressive technologies and methodologies to overcoming impediment challenges and risk to mankind by collaborating the translation and exchange of emerging ideas and advancements. Focus to develop the field of medical virology by promoting progressive technologies and convergence areas of research that have not been utilised previously. Blending with distinct research fields results in progressive approaches to work on infectious diseases caused by viruses.

The advancement of potential assays for the diagnosis of these diseases as result of current observations in the viral aetiology of many infectious diseases, and considerable progress in our insight of the history and the steps of the viral life cycle, pathogenesis and chemotherapy of infectious diseases.

  • Track 18-1Recombinant Viruses as gene therapy Vectors
  • Track 18-2Synthetic viruses
  • Track 18-3Fusion of viral membrane
  • Track 18-4Next-generation sequencing
  • Track 18-5Viruses are using fats to penetrate a cell
  • Track 18-6Using microarrays in virology
  • Track 18-7Retroviral vectors for gene therapy
  • Track 18-8Adinoviral vectors for gene therapy
  • Track 18-9Immunotherapy as HIV treatment

Contemporary management of infectious viruses such as HIV, Ebola virus, Human parainfluenza viruses (HPIV), Hepatitis, Flu are  catering a new way for the integration of molecular techniques into management of chronic viral infections. Such progresses are not only emphasizing the use of diagnostic virology also amendment the field of virology techniques.  

  • Track 19-1Reverse transcription
  • Track 19-2Integrase
  • Track 19-3Transcription
  • Track 19-4Translation
  • Track 19-5Protease inhibitors
  • Track 19-6Release phase
  • Track 19-7Before cell entry
  • Track 19-8Entry inhibitor
  • Track 19-9Uncoating inhibitor

Viral Bioweapons are the viral living organisms which reproduce and replicates within their host victims. They are the biological toxins with an intention to kill humans,animals or plants. High infectivity, High virulence, Non-availabilty of vaccines and efficient delivery system are the main characteristics of a bioweapon. Ebola virus, Rift valley fever virus, Japanese encephalitis virus, Yellow fever virus are the viral agents used as bioweapons. Bioweapons also target fisheries,water based vegetations,target plants to destroy crops and defoliate vegetation in agriculture. Aerial spray tanks and cluster bombs are used as bioweapons for the treatment of wheat blast and rice blast disease. Bioherbicides and Mycoherbicides are used as bioweapons. Bioterrorism is the terrorism which involves the intentional release of biological agents such as viruses.

  • Track 20-1Ebola Virus,Rift Valley Fever Virus
  • Track 20-2Japanese Encephalitis
  • Track 20-3Bioherbicides and Mycoherbicides
  • Track 20-4Bioterrorism and Biosurvelliance
  • Track 20-5Modern Bioweapon Operations
  • Track 20-6Identification of Bioweapons and Genetic Warfare

More than half of the century, scientists, doctors and clinicians have been utilising earlier antibiotics to treat infectious diseases caused by pathogenic bacteria. Even though, emergence of bacterial resistance to antibiotics following widespread clinical, veterinary, and animal or agricultural management being less effective for antibiotics. Recent reports are showing that scientists are facing the threat of superbugs, i.e. pathogenic bacteria resistant to most or all available antibiotics. Pharmaceutical companies being focused on the development of novel products derived from bacteriophages as antimicrobial agents. 

  • Track 21-1Lytic phage as antibacterial therapeutics
  • Track 21-2Phage as antibacterial Nano-medicines
  • Track 21-3Phage application in Agriculture and food industry
  • Track 21-4To eradicate biofilms
  • Track 21-5Clinical Studies
  • Track 21-6Animal Models for Treatment of Infectious Diseases
  • Track 21-7Enzymes as Antibacterial Therapeutic Agents
  • Track 21-8Bacteriophage Tail-Associated Lytic
  • Track 21-9Lysozyme to Treat Bacterial Contamination in Plant Cell Cultures
  • Track 21-10As Curative Agents
  • Track 21-11As Prophylactic Agents
  • Track 21-12Phage DNA Vaccine
  • Track 21-13Phage Display Vaccine
  • Track 21-14To treat bacterial infections in animals and birds
  • Track 21-15Bactericidal to treat human infections
  • Track 21-16Bacterial pathogens

The agricultural inoculants industry when quoted in appraisal is envisaged to reach about $398.56 million by the year 2019, at a CAGR of about 9.5% from 2014.

Plant Virology is a field of Plant Pathology and Environmental sciences. Plant Pathology deals with Viruses & Virus like Pathogens and Diseases. In Plant Pathology major courses are Horticulture and Crop Science, Entomology or Microbiology.  Tobacco mosaic infection (TMV) is a positive-sense single stranded RNA virus that taints an extensive variety of plants, particularly tobacco and different individuals from the family Solanaceae. Most plant viruses are RNA although some 80+ Viruses or DNA Viruses. Basically Plant viruses Genomes are comprises in Coding Region and Non coding Region Coding Region It expresses the proteins required to Viral Infection Cycle

  • Track 22-1Viral vector biology and transmission
  • Track 22-2Tobacco virus
  • Track 22-3Vegetable viruses
  • Track 22-4Wheat and rice viruses
  • Track 22-5Biotechnology in plant viral diseases
  • Track 22-6Plant virus epidemiology, ecology and evolution
  • Track 22-7Host factors involved in virus multiplication
  • Track 22-8Genome Organization & Replication (RNA, dsRNA, DNA Viruses)
  • Track 22-9Sub viral Agents
  • Track 22-10Horticulture and Crop Science
  • Track 22-11Plant Viruses
  • Track 22-12Plants virus-vector interactions
  • Track 22-13Interaction with host
  • Track 22-14Grape wine leaf roll disease